Latest Market Research Report 2025

The global proteomics market   was valued at   USD 24.29 billion   in 2023 and is projected to grow at a   compound annual growth rate (CAGR) of 13.10%   from 2024 to 2030. This robust growth is driven by several key factors, including the rising prevalence of   chronic and infectious diseases, the increasing demand for   advanced diagnostic solutions   for targeted disease treatment, and the growing need for   personalized medicine. Additionally,   technological advancements in protein analysis are further fueling the market's expansion, providing more precise tools for disease diagnosis and therapy. Factors Driving Market Growth: One of the primary drivers of the proteomics market is the increasing prevalence of chronic and infectious diseases worldwide. The World Health Organization (WHO) projects that the number of new cancer cases will rise to over 35 million by 2050, a 77% increase from the approximate...

  The global proteomics market was valued at USD 24.29 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 13.10% from 2024 to 2030. Several key factors are contributing to this significant growth, including the increasing prevalence of chronic and infectious diseases, the rising demand for rapid and advanced diagnostic solutions for targeted disease treatment, and the growing emphasis on personalized medicine. Additionally, ongoing technological advancements in protein analysis and proteomic tools are further propelling the expansion of the market. One of the primary drivers of the proteomics market is the increasing occurrence of chronic and infectious diseases worldwide. For instance, the World Health Organization (WHO) has projected that by 2050, there will be over 35 million new cases of cancer annually, a sharp rise of 77% compared to the 20 million cases estimated in 2022. This rising incidence of chronic diseases, including cancer, diabetes...

  The global proteomics market was valued at USD 24.29 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 13.10% from 2024 to 2030. Several key factors are contributing to this significant growth, including the increasing prevalence of chronic and infectious diseases, the rising demand for rapid and advanced diagnostic solutions for targeted disease treatment, and the growing emphasis on personalized medicine. Additionally, ongoing technological advancements in protein analysis and proteomic tools are further propelling the expansion of the market. One of the primary drivers of the proteomics market is the increasing occurrence of chronic and infectious diseases worldwide. For instance, the World Health Organization (WHO) has projected that by 2050, there will be over 35 million new cases of cancer annually, a sharp rise of 77% compared to the 20 million cases estimated in 2022. This rising incidence of chronic diseases, including cancer, diabetes...